Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

FDC Ltd. Regulatory Filings 2021

Jul 8, 2021

60812_rns_2021-07-08_f03a0729-c0d4-460a-bf69-58b93a17067c.pdf

Regulatory Filings

Open in viewer

Opens in your device viewer

MANUFACTURERS & EXPORTERS OF FOODS, DRUGS & CHEMICALS

Date :- July 08, 2021

BSELimited Phiroze Jeejeebhoy Towers, Dalal Street, Mumbai - 400001

National Stock Exchange of India Ltd. Exchange Plaza, Plot no. C/l, G Block, Bandra-Kurla Complex, Bandra (E), Mumbai - 400 051

BSEScrip Code: 531599 NSESymbol - FDC

Sub: - Clarification on news article published in Economic Times (ET) dated July 08, 2021 captioned as "FDC Looking to Demerge its Top OTC Brands into Separate Entity",

Dear Sir/Madam,

This is to bring to your kind attention that we have come across a news article published in Economic Times today by Mr. Reghu Balakrishnan and Mr. Indulal PM captioned as "FDC Looking to Demerge its Top OTC Brands into Separate Entity".

We hereby clarify that the said article is erroneous and has the potential to mislead the Investors.

Given the seriousness of such an article being circulated/published and its consequential likely impact on the investors, we are issuing this letter in the larger public interest. We request all the stakeholders to not to be misled by such information in the newspapers/social media.

You are requested to take the same on your record.

Thanking You,

Yours faithfully, #

  • ~

Varsharani Katre Company Secretary